Comparable study will come when the board get's to that point i.e. to take full FDA approval. They have not done comparable study else we would have not done this panco register establishment. One of the poster here explained that in past company in a rush to get CE marking agree to get panco register established and that is why we are here without comparable trial results... IMO.
Also lack of comparable trial reason was behind TGA withdrawal from the company if i am not wrong.
i am not excited today's announcement as price sensitive when they simply ignored the trail established in hong-kong and didn't bother releasing it to the market all to gather.
next key announcement will be outcome of HD listing approval response from FDA (it will come by March 22 .. IMO) or when the sell in UK commence or company clarifies whey they can't sell any device in EU & UK.. IMO.
OSL Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)